Chiara Falcomatà

1.4k total citations · 1 hit paper
12 papers, 279 citations indexed

About

Chiara Falcomatà is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Chiara Falcomatà has authored 12 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Chiara Falcomatà's work include Pancreatic and Hepatic Oncology Research (4 papers), Phagocytosis and Immune Regulation (3 papers) and Cancer Research and Treatments (3 papers). Chiara Falcomatà is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Phagocytosis and Immune Regulation (3 papers) and Cancer Research and Treatments (3 papers). Chiara Falcomatà collaborates with scholars based in Germany, United States and Italy. Chiara Falcomatà's co-authors include Dieter Saur, Stefanie Bärthel, Roland Rad, Günter Schneider, Marc Schmidt‐Supprian, Fabian J. Theis, Federica Di Nicolantonio, Jaime Mateus-Tique, Monica Pradotto and Alessia Baccarini and has published in prestigious journals such as Cell, Nature Communications and Cancer Research.

In The Last Decade

Chiara Falcomatà

10 papers receiving 277 citations

Hit Papers

Context-Specific Determinants of the Immunosuppressive Tu... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Falcomatà Germany 7 166 121 97 56 22 12 279
Rachel A. Woolaver United States 9 158 1.0× 144 1.2× 132 1.4× 53 0.9× 16 0.7× 12 317
Brian J. Mog United States 6 169 1.0× 124 1.0× 132 1.4× 49 0.9× 41 1.9× 10 291
Zeinab Ghazvinian Iran 6 152 0.9× 97 0.8× 68 0.7× 63 1.1× 55 2.5× 8 283
Shujun Xing China 6 190 1.1× 92 0.8× 116 1.2× 32 0.6× 25 1.1× 11 282
Lucia Demková Slovakia 9 161 1.0× 185 1.5× 42 0.4× 70 1.3× 24 1.1× 15 334
Zhitong Niu China 5 138 0.8× 191 1.6× 98 1.0× 93 1.7× 30 1.4× 6 331
Corey Gallen United States 4 137 0.8× 87 0.7× 143 1.5× 45 0.8× 16 0.7× 6 281
Malica Yalamanchili United States 3 261 1.6× 150 1.2× 85 0.9× 80 1.4× 25 1.1× 3 341
Elena Menietti Switzerland 5 219 1.3× 174 1.4× 69 0.7× 81 1.4× 15 0.7× 7 357

Countries citing papers authored by Chiara Falcomatà

Since Specialization
Citations

This map shows the geographic impact of Chiara Falcomatà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Falcomatà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Falcomatà more than expected).

Fields of papers citing papers by Chiara Falcomatà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Falcomatà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Falcomatà. The network helps show where Chiara Falcomatà may publish in the future.

Co-authorship network of co-authors of Chiara Falcomatà

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Falcomatà. A scholar is included among the top collaborators of Chiara Falcomatà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Falcomatà. Chiara Falcomatà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Maione, Federica, Daniele Oddo, Chiara Falcomatà, et al.. (2024). Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models. Molecular Oncology. 18(6). 1552–1570. 4 indexed citations
2.
Mollaoglu, Gürkan, Alexander Tepper, Chiara Falcomatà, et al.. (2024). Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 187(26). 7492–7510.e22. 33 indexed citations
3.
Falcomatà, Chiara, et al.. (2023). Dual Recombinase–Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy. Cancer Research. 83(14). 2279–2282. 4 indexed citations
4.
Falcomatà, Chiara, Stefanie Bärthel, Günter Schneider, et al.. (2023). Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer. Cancer Discovery. 13(2). 278–297. 111 indexed citations breakdown →
5.
Bärthel, Stefanie, Chiara Falcomatà, Ankit Sinha, et al.. (2023). Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. Nature Communications. 14(1). 2642–2642. 16 indexed citations
6.
Bärthel, Stefanie, Chiara Falcomatà, Roland Rad, Fabian J. Theis, & Dieter Saur. (2023). Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy. Nature Cancer. 4(4). 454–467. 49 indexed citations
7.
Schneeweis, Christian, Zonera Hassan, Chiara Falcomatà, et al.. (2022). AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer. Cellular and Molecular Life Sciences. 80(1). 12–12. 6 indexed citations
8.
Saur, Dieter, et al.. (2022). Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer. Journal of Visualized Experiments.
9.
Saur, Dieter, et al.. (2022). Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer. Journal of Visualized Experiments.
10.
Falcomatà, Chiara, Stefanie Bärthel, Günter Schneider, Dieter Saur, & Christian Veltkamp. (2019). Deciphering the universe of genetic context-dependencies using mouse models of cancer. Current Opinion in Genetics & Development. 54. 97–104. 3 indexed citations
11.
Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations
12.
Sartore‐Bianchi, Andrea, Filippo Pietrantonio, Alessio Amatu, et al.. (2016). Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients. European Journal of Cancer. 71. 43–50. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026